Published in Clin Exp Immunol on January 01, 2007
Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol (2010) 5.59
Inflammation and uncoupling as mechanisms of periodontal bone loss. J Dent Res (2010) 1.45
Drugs, medications and periodontal disease. Br Dent J (2014) 1.44
Review of osteoimmunology and the host response in endodontic and periodontal lesions. J Oral Microbiol (2011) 1.42
Lessons learned and unlearned in periodontal microbiology. Periodontol 2000 (2013) 1.30
Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 (2014) 1.20
Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis. Periodontol 2000 (2010) 1.17
Diabetes aggravates periodontitis by limiting repair through enhanced inflammation. FASEB J (2011) 1.09
Oral inflammatory diseases and systemic inflammation: role of the macrophage. Front Immunol (2012) 1.07
Simultaneous analysis of T helper subsets (Th1, Th2, Th9, Th17, Th22, Tfh, Tr1 and Tregs) markers expression in periapical lesions reveals multiple cytokine clusters accountable for lesions activity and inactivity status. J Appl Oral Sci (2014) 1.01
An interleukin-1beta (IL-1beta) single-nucleotide polymorphism at position 3954 and red complex periodontopathogens independently and additively modulate the levels of IL-1beta in diseased periodontal tissues. Infect Immun (2008) 1.00
Altered oral viral ecology in association with periodontal disease. MBio (2014) 0.95
Dose-response met-RANTES treatment of experimental periodontitis: a narrow edge between the disease severity attenuation and infection control. PLoS One (2011) 0.94
AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression. Gene Ther (2008) 0.93
Restoring host-microbe homeostasis via selective chemoattraction of Tregs. J Dent Res (2014) 0.92
The potential role of suppressors of cytokine signaling in the attenuation of inflammatory reaction and alveolar bone loss associated with apical periodontitis. J Endod (2008) 0.88
The role of osteoimmunology in periodontal disease. Biomed Res Int (2013) 0.88
The enduring importance of animal models in understanding periodontal disease. Virulence (2015) 0.87
Host Responses in the Link Between Periodontitis and Rheumatoid Arthritis. Curr Oral Health Rep (2015) 0.83
Experimental alveolitis in rats: microbiological, acute phase response and histometric characterization of delayed alveolar healing. J Appl Oral Sci (2011) 0.83
Inflammation Biomarkers of Advanced Disease in Nongingival Tissues of Chronic Periodontitis Patients. Mediators Inflamm (2015) 0.83
IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitis. J Bone Miner Res (2015) 0.82
An experimental model of meningoencephalomyelitis by Rocio flavivirus in BALB/c mice: inflammatory response, cytokine production, and histopathology. Am J Trop Med Hyg (2011) 0.82
Plasmodium falciparum infection induces expression of a mosquito salivary protein (Agaphelin) that targets neutrophil function and inhibits thrombosis without impairing hemostasis. PLoS Pathog (2014) 0.81
Intramembranous bone healing process subsequent to tooth extraction in mice: micro-computed tomography, histomorphometric and molecular characterization. PLoS One (2015) 0.80
Porphyromonas gingivalis, gamma interferon, and a proapoptotic fibronectin matrix form a synergistic trio that induces c-Jun N-terminal kinase 1-mediated nitric oxide generation and cell death. Infect Immun (2008) 0.80
Non-inflammatory destructive periodontal disease: a clinical, microbiological, immunological and genetic investigation. J Appl Oral Sci (2012) 0.78
The expression of a nitric oxide derivative, tissue inhibitors of metalloproteinase-3, and tissue inhibitors of metalloproteinase-4 in chronic periodontitis with type 2 diabetes mellitus. J Periodontal Implant Sci (2013) 0.78
Gene expression dynamics during diabetic periodontitis. J Dent Res (2012) 0.78
The novel role of HtrA1 in gingivitis, chronic and aggressive periodontitis. PLoS One (2014) 0.77
Lack of Proinflammatory Cytokine Interleukin-6 or Tumor Necrosis Factor Receptor-1 Results in a Failure of the Innate Immune Response after Bacterial Meningitis. Mediators Inflamm (2016) 0.77
Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis. Infect Immun (2016) 0.76
Intragingival injection of Porphyromonas gingivalis-derived lipopolysaccharide induces a transient increase in gingival tumour necrosis factor-α, but not interleukin-6, in anaesthetised rats. Int J Oral Sci (2015) 0.75
NADPH oxidase contributes to resistance against Aggregatibacter actinomycetemcomitans-induced periodontitis in mice. Infect Immun (2016) 0.75
Aggregatibacter actinomycetemcomitans biofilm killing by a targeted ciprofloxacin prodrug. Biofouling (2013) 0.75
Changes in periodontium after extraction of a periodontally-involved tooth in rats. J Periodontal Implant Sci (2012) 0.75
Simvastatin modulates gingival cytokine and MMP production in a rat model of ligature-induced periodontitis. Clin Cosmet Investig Dent (2017) 0.75
Acute-phase proteins and other systemic responses to inflammation. N Engl J Med (1999) 18.25
Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65
Bone resorption by osteoclasts. Science (2000) 11.68
Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell (1993) 9.84
Matrix metalloproteinases: a review. Crit Rev Oral Biol Med (1993) 9.03
Proinflammatory cytokines. Chest (2000) 5.89
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol (2004) 5.07
Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity (1999) 4.47
TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol (1998) 4.32
IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest (2005) 3.56
The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol (2003) 2.83
Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem (2000) 2.80
Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis (2000) 2.79
Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J Immunol (1997) 2.51
IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol (1998) 2.45
Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest (1997) 2.23
Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today (2000) 1.65
Confrontation between intracellular bacteria and the immune system. Adv Immunol (1999) 1.61
Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect (2003) 1.59
A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol (1998) 1.53
Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res (2003) 1.46
Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice. J Immunol (2001) 1.45
Kinetics of nitric oxide and hydrogen peroxide production and formation of peroxynitrite during the respiratory burst of human neutrophils. FEBS Lett (1994) 1.41
Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol (2006) 1.40
Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol (2001) 1.36
Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol (2004) 1.32
Chemokines in human periodontal disease tissues. Clin Exp Immunol (2001) 1.28
Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J Leukoc Biol (2001) 1.26
T cell knockout mice have diminished alveolar bone loss after oral infection with Porphyromonas gingivalis. FEMS Immunol Med Microbiol (2002) 1.16
A perspective on the potential cardioprotective benefits of periodontal therapy. Am Heart J (2005) 1.16
The role of immune responses in bone loss during periodontal disease. Microbes Infect (2000) 1.15
Clinical, pathological and immunological aspects of periodontal disease. Acta Odontol Scand (2001) 1.15
Polymorphonuclear neutrophils and their mediators in gingival tissues from generalized aggressive periodontitis. J Periodontol (2001) 1.12
Actinobacillus actinomycetemcomitans-induced periodontal disease in mice: patterns of cytokine, chemokine, and chemokine receptor expression and leukocyte migration. Microbes Infect (2005) 1.05
Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res (2001) 1.02
Specific antibodies and their potential role in periodontal diseases. J Periodontol (1993) 0.91
The influence of interleukin gene polymorphism on expression of interleukin-1beta and tumor necrosis factor-alpha in periodontal tissue and gingival crevicular fluid. J Periodontol (1999) 0.90
Exacerbated febrile responses to LPS, but not turpentine, in TNF double receptor-knockout mice. Am J Physiol (1997) 0.89
Tumor necrosis factors in 1996. Cytokine Growth Factor Rev (1996) 0.87
Genetic susceptibility to chronic periodontal disease. Microbes Infect (2002) 0.87
Role of C-reactive protein in cardiovascular disease. Ann Pharmacother (2004) 0.87
Antigenically diverse reference strains and autologous strains of Actinobacillus actinomycetemcomitans are equally efficient antigens in enzyme-linked immunosorbent assay analysis. J Clin Microbiol (2002) 0.87
Clinical, radiographic and biochemical assessment of IL-1/TNF-alpha antagonist inhibition of bone loss in experimental periodontitis. J Clin Periodontol (2002) 0.85
Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res (2001) 0.83
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96
A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci U S A (2005) 2.53
Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun (1994) 2.35
Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun (1996) 2.18
Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol (2000) 2.16
Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun (1995) 1.94
Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun (1996) 1.93
Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol (1994) 1.82
Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation (2000) 1.82
Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol (1993) 1.79
Tool support for authoring eligibility criteria for cancer trials. Proc AMIA Symp (1999) 1.73
Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions (1990) 1.71
IL-10 mediates susceptibility to Trypanosoma cruzi infection. J Immunol (1994) 1.70
Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res (2007) 1.65
Modulation of mucosal immunity in a murine model of food-induced intestinal inflammation. Clin Exp Allergy (2007) 1.65
Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect (2000) 1.63
An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res (2004) 1.56
IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology (1991) 1.54
Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol (2009) 1.45
beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect Immun (1999) 1.44
Mouse paw edema. A new model for inflammation? Braz J Med Biol Res (1987) 1.42
Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol (2006) 1.40
The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol (2009) 1.39
An electronic pressure-meter nociception paw test for rats. Braz J Med Biol Res (2004) 1.39
Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol (2001) 1.36
Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis (2000) 1.30
The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience (2001) 1.30
Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A (2008) 1.28
Interferon-gamma and tumor necrosis factor-alpha determine resistance to Paracoccidioides brasiliensis infection in mice. Am J Pathol (2000) 1.26
A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5. Br J Pharmacol (2009) 1.23
Multivariate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. II. Treatment by intrahepatic chemotherapy. Ann Surg (1984) 1.23
Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis. Eur J Pharmacol (2000) 1.21
Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med (1992) 1.20
Growth phase-dependent subcellular localization of nitric oxide synthase in maize cells. FEBS Lett (1999) 1.19
Functional activities of rosette separated human peripheral blood leukocytes. J Immunol (1975) 1.19
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br J Pharmacol (1995) 1.17
Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect Immun (1999) 1.17
Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br J Pharmacol (1997) 1.15
Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol (2000) 1.14
Neutrophil migration induced by inflammatory stimuli is reduced by macrophage depletion. Agents Actions (1988) 1.13
Sequential induction of nitric oxide synthase by Corynebacterium parvum in different organs of the mouse. Br J Pharmacol (1995) 1.12
Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol Lett (1998) 1.12
The release of a neutrophil chemotactic factor from peritoneal macrophages by endotoxin: inhibition by glucocorticoids. Eur J Pharmacol (1986) 1.12
Tumour necrosis factor-alpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation. Br J Pharmacol (2001) 1.12
Periodontitis and arthritis interaction in mice involves a shared hyper-inflammatory genotype and functional immunological interferences. Genes Immun (2010) 1.11
Failure to provide clinicians useful IT systems: opportunities to leapfrog current technologies. Methods Inf Med (2008) 1.11
Heme oxygenase/carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br J Pharmacol (2006) 1.10
In vitro human reactivity to staphylococcal phage lysate. J Immunol (1975) 1.09
Successive tick infestations selectively promote a T-helper 2 cytokine profile in mice. Immunology (1999) 1.08
Analgesic effect of thalidomide on inflammatory pain. Eur J Pharmacol (2000) 1.06
Saliva of Rhipicephalus sanguineus tick impairs T cell proliferation and IFN-gamma-induced macrophage microbicidal activity. Vet Immunol Immunopathol (1998) 1.05
Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis. Infect Immun (2006) 1.05
Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol (2000) 1.04
Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br J Pharmacol (1999) 1.02
Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect Immun (2002) 1.01
iNOS-derived nitric oxide modulates infection-stimulated bone loss. J Dent Res (2008) 1.00
Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus. Br J Pharmacol (2002) 0.99
The involvement of nitric oxide in the anti-Candida albicans activity of rat neutrophils. Immunology (1996) 0.99
Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. Infect Immun (1999) 0.98
Recurrent and chronic appendicitis. Surg Gynecol Obstet (1986) 0.98
Treatment of Paracoccidioides brasiliensis-infected mice with a nitric oxide inhibitor prevents the failure of cell-mediated immune response. J Immunol (1998) 0.98
Decreased gastric tone and delayed gastric emptying precede neutrophil infiltration and mucosal lesion formation in indomethacin-induced gastric damage in rats. Braz J Med Biol Res (2003) 0.98
Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice. Br J Pharmacol (2008) 0.98
Tumor necrosis factor-alpha and interleukin-1beta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J Urol (2002) 0.98
Induction of NOS in rat blood PMN in vivo and in vitro: modulation by tyrosine kinase and involvement in bactericidal activity. J Leukoc Biol (1999) 0.97
Inducible cyclooxygenase released prostaglandin mediates immunosuppression in acute phase of experimental Trypanosoma cruzi infection. Exp Parasitol (2005) 0.97
Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats. Br J Pharmacol (2007) 0.97
Expression of suppressors of cytokine signaling in diseased periodontal tissues: a stop signal for disease progression? J Periodontal Res (2006) 0.97
Atorvastatin inhibits inflammatory hypernociception. Br J Pharmacol (2006) 0.96
Role of nitric oxide on pathogenesis of 5-fluorouracil induced experimental oral mucositis in hamster. Cancer Chemother Pharmacol (2006) 0.95
Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast. Ann Surg (1983) 0.95
Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells. Inflammation (2008) 0.95
Recombinant gamma interferon causes neutrophil migration mediated by the release of a macrophage neutrophil chemotactic factor. Int J Exp Pathol (1990) 0.94
A model of hemorrhagic cystitis induced with acrolein in mice. Braz J Med Biol Res (2006) 0.93
Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection. J Periodontal Res (2008) 0.93
Acute-phase protein alpha-1-acid glycoprotein mediates neutrophil migration failure in sepsis by a nitric oxide-dependent mechanism. Proc Natl Acad Sci U S A (2007) 0.93